Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tislelizumab programmed cell death protein 1 biotech Successful target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hodgkin Disease[MeSHID:D006689]
Liver carcinoma[MeSHID:D006528]		 9.09 investigational,approved antagonist,inhibitor
tislelizumab programmed cell death protein 1 biotech Successful target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hodgkin Disease[MeSHID:D006689]
Liver carcinoma[MeSHID:D006528]		 9.09 investigational,approved antagonist,inhibitor,antibody
click here to return to the previous page